<VariationArchive RecordType="classified" VariationID="804110" VariationName="NM_000033.4(ABCD1):c.1853del (p.Met618fs)" VariationType="Deletion" Accession="VCV000804110" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-10-01" DateCreated="2020-01-11" MostRecentSubmission="2020-01-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="792149" VariationID="804110">
      <GeneList>
        <Gene Symbol="ABCD1" FullName="ATP binding cassette subfamily D member 1" GeneID="215" HGNC_ID="HGNC:61" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153724856" stop="153744755" display_start="153724856" display_stop="153744755" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152990322" stop="153010215" display_start="152990322" display_stop="153010215" Strand="+" />
          </Location>
          <OMIM>300371</OMIM>
          <Haploinsufficiency last_evaluated="2020-12-02" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ABCD1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-12-02" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ABCD1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000033.4(ABCD1):c.1853del (p.Met618fs)</Name>
      <CanonicalSPDI>NC_000023.11:153743058:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153743059" stop="153743059" display_start="153743059" display_stop="153743059" variantLength="1" positionVCF="153743058" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153008513" stop="153008513" display_start="153008513" display_stop="153008513" variantLength="1" positionVCF="153008512" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>M618fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.153008513del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.153008513del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.153743059del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.153743059del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009022.2" sequenceAccession="NG_009022" sequenceVersion="2" change="g.23192del">
            <Expression>NG_009022.2:g.23192del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000033.4" sequenceAccession="NM_000033" sequenceVersion="4" change="c.1853del" MANESelect="true">
            <Expression>NM_000033.4:c.1853del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000024.2" sequenceAccession="NP_000024" sequenceVersion="2" change="p.Met618fs">
            <Expression>NP_000024.2:p.Met618fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1017" sequenceAccession="LRG_1017">
            <Expression>LRG_1017:g.23192del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1017t1" sequenceAccession="LRG_1017t1">
            <Expression>LRG_1017t1:c.1853del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1017p1" sequenceAccession="LRG_1017p1" change="p.Met618fs">
            <Expression>LRG_1017p1:p.Met618fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1603235941" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000033.4(ABCD1):c.1853del (p.Met618fs) AND Adrenoleukodystrophy" Accession="RCV000990981" Version="1">
        <ClassifiedConditionList TraitSetID="3100">
          <ClassifiedCondition DB="MedGen" ID="C0162309">Adrenoleukodystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-05-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-05-28" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-01-11" MostRecentSubmission="2020-01-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3100" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="139" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ADDISON DISEASE AND CEREBRAL SCLEROSIS</ElementValue>
                <XRef Type="MIM" ID="300100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BRONZE SCHILDER DISEASE</ElementValue>
                <XRef Type="MIM" ID="300100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MELANODERMIC LEUKODYSTROPHY</ElementValue>
                <XRef Type="MIM" ID="300100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SIEMERLING-CREUTZFELDT DISEASE</ElementValue>
                <XRef Type="MIM" ID="300100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Adrenoleukodystrophy</ElementValue>
                <XRef ID="Adrenoleukodystrophy/242" DB="Genetic Alliance" />
                <XRef ID="MONDO:0018544" DB="MONDO" />
                <XRef ID="65389002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">X-ALD</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">ALD</ElementValue>
                <XRef Type="MIM" ID="300100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">Adrenoleukodystrophy, ID</ElementValue>
                <XRef ID="GTR000500811" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000318975" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330513" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500811" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500892" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507942" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508448" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520051" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521375" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522267" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522268" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530118" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000559496" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000503088" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512569" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522163" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000070507" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000503092" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000519128" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000561876" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">X-linked adrenoleukodystrophy (X-ALD) affects the nervous system white matter and the adrenal cortex. Three main phenotypes are seen in affected males: The childhood cerebral form manifests most commonly between ages four and eight years. It initially resembles attention-deficit disorder or hyperactivity; progressive impairment of cognition, behavior, vision, hearing, and motor function follow the initial symptoms and often lead to total disability within six months to two years. Most individuals have impaired adrenocortical function at the time that neurologic disturbances are first noted. Adrenomyeloneuropathy (AMN) manifests most commonly in an individual in his twenties or middle age as progressive stiffness and weakness of the legs, sphincter disturbances, sexual dysfunction, and often, impaired adrenocortical function; all symptoms are progressive over decades. "Addison disease only" presents with primary adrenocortical insufficiency between age two years and adulthood and most commonly by age 7.5 years, without evidence of neurologic abnormality; however, some degree of neurologic disability (most commonly AMN) usually develops by middle age. More than 20% of female carriers develop mild-to-moderate spastic paraparesis in middle age or later. Adrenal function is usually normal.</Attribute>
                <XRef ID="NBK1315" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301491</ID>
                <ID Source="BookShelf">NBK1315</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">22071894</ID>
              </Citation>
              <XRef ID="43" DB="Orphanet" />
              <XRef ID="C0162309" DB="MedGen" />
              <XRef ID="MONDO:0018544" DB="MONDO" />
              <XRef Type="MIM" ID="300100" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2247864" SubmissionDate="2019-10-22" DateLastUpdated="2020-01-11" DateCreated="2020-01-11">
        <ClinVarSubmissionID localKey="NC_000023.10:g.153008513delT|OMIM:300100" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001142061" DateUpdated="2020-01-11" DateCreated="2020-01-11" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ABCD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.153008513delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300100" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_020</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2247864" TraitType="Disease" MappingType="XRef" MappingValue="300100" MappingRef="OMIM">
        <MedGen CUI="C0162309" Name="Adrenoleukodystrophy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

